Fact CheckerSign in

NCT06302777Recruiting

MAIN-IMAGE Registry

Multifactorial Analysis of Coronary Artery Plaques Using INtracoronary IMAGing for Exploration of Atherosclerotic Determinants and Progression - the MAIN-IMAGE Registry

Source: ClinicalTrials.gov · Last updated 12 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

All comers registry with patients with chronic coronary syndrome or acute coronary syndrome who underwent intracoronary imaging during cardiac catherization. The aim is to identify plaque characteristics on OCT or IVUS that are associated with adverse cardiac events including myocardial infarction and atherosclerotic progression.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
4 Mar 2024
Start date
26 Sept 2023
Primary completion date
26 Sept 2028
Lead sponsor
Goethe University
NCT number
NCT06302777

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 26 Sept 2023 to the primary completion date, 26 Sept 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • patients undergoing pre-intervention optical coherence tomography imaging

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Frankfurt University Hospital
Coordinator of this site? Confirm its status
FrankfurtGermanyRecruiting
Frankfurt University Hospital
Coordinator of this site? Confirm its status
Frankfurt am MainGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.